Union Korea Pharm Co., Ltd. (KOSDAQ:080720)
2,725.00
0.00 (0.00%)
At close: Oct 2, 2025
Union Korea Pharm Revenue
Union Korea Pharm had revenue of 10.15B KRW in the quarter ending June 30, 2025, a decrease of -32.52%. This brings the company's revenue in the last twelve months to 42.47B, down -33.87% year-over-year. In the year 2024, Union Korea Pharm had annual revenue of 51.28B, down -18.82%.
Revenue (ttm)
42.47B
Revenue Growth
-33.87%
P/S Ratio
0.46
Revenue / Employee
255.86M
Employees
166
Market Cap
19.70B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 51.28B | -11.89B | -18.82% |
Dec 31, 2023 | 63.17B | 1.88B | 3.06% |
Dec 31, 2022 | 61.29B | 12.99B | 26.89% |
Dec 31, 2021 | 48.30B | -2.08B | -4.12% |
Dec 31, 2020 | 50.38B | -885.13M | -1.73% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.16T |
Samsung Biologics | 5,031.69B |
Hanwha Aerospace | 19.25T |
Hyundai Motor Company | 182.25T |
HD Hyundai Heavy Industries | 15.58T |
KB Financial Group | 14.92T |